Presentation on theme: "Tony Davis CEO of Medilink WMAHSN Working With Industry and Wealth Creation."— Presentation transcript:
Tony Davis CEO of Medilink WMAHSN Working With Industry and Wealth Creation
WMAHSN working with industry WMAHSN a strong and effective partnership between industry, academia, and health A partnership that co-creates innovative solutions to healthcare challenges in the region which are designed to transform the experience of patients A collaboration for ensuring the adoption and spread of proven innovations that deliver measurable benefit to patients, the population, members and partners
Some considerations for the first year of WMAHSNs M apping of priorities from WMAHSN and facilitating the grouping of industries around disease and service groups An overarching compact between WMAHSN and industry that would reflect the ethical framework needed to effective partnership workings A governance and delivery structure for industry engagement and wealth creation Further work needed on metrics to measure both collaboration and the contribution of WMAHSNs to wealth creation and on information governance/data sharing Creating the pipeline of future innovations – ensuring an unambiguous case for spread and supporting the subtleties of local adoption
WMAHSN and industry working together across the key levers and linkages identified in the AHSN guidance, emphasizing the importance of building relationships and aligning the levers: research participation translating research and learning into practice education and training service improvement information wealth creation.
The Vision The DH ‘Business Department’ The NHSE an ‘Engine for Growth’
WMAHSN Wealth Creation “AHSNs will facilitate the translation of ideas into commercial products and services, in partnership with industry and academia, along the whole innovation journey, creating wealth and improving healthcare provision.”
WMAHSN wealth creation will take many forms. Not only the development and widespread adoption of new products and services.. Also job creation, export opportunities and new revenue streams for companies and NHS organisations. WMAHSN will also work with UKTI-LSI, LEPs and LAs to encourage inward investment into the region as well as working with Healthcare UK on exporting WMAHSN expertise to other markets.
WMAHSN has the potential to stimulate wealth creation in industry by…. facilitating the development and accelerated adoption of products and services by enabling appropriate access to the network of AHSNs across England.
WMAHSN will provide impartial advice and importantly access for private and third sector organisations to networks which include local authorities, economic partnerships, industry trade organisations and the AHSN network across England. For the life sciences sector, the WMAHSN will be a source of natural collaborators: to address existing or emerging healthcare challenges, providing wealth creation opportunities.